Gilleece YC - Search Results

1

The efficacy of lopinavir in individuals experiencing protease inhibitor failure.

Gilleece YC, Qazi NA, Morlese JF, Mandalia S, Gazzard BG, Pozniak AL, Nelson MR. Gilleece YC, et al. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):238-40. doi: 10.1097/00126334-200302010-00018. J Acquir Immune Defic Syndr. 2003. PMID: 12571536 Clinical Trial. No abstract available.

2

R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naive patients with M184V.

Torti C, Gilleece Y, Hertogs K, Gazzard BG, Pozniak AL. Torti C, et al. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):514-5. doi: 10.1097/00126334-200104150-00022. J Acquir Immune Defic Syndr. 2001. PMID: 11391177 No abstract available.

3

Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?

Gilleece Y, Nelson M. Gilleece Y, et al. J HIV Ther. 2001 May;6(2):37-9. J HIV Ther. 2001. PMID: 11501202 Review. No abstract available.

4

Can targeted HIV testing campaigns alter health-seeking behaviour?

McOwan A, Gilleece Y, Chislett L, Mandalia S. McOwan A, et al. AIDS Care. 2002 Jun;14(3):385-90. doi: 10.1080/09540120220123766. AIDS Care. 2002. PMID: 12042083

5

The safety and tolerability of switching from a non-failing antiretroviral regimen to lopinavir.

Gilleece Y, Mandalia S, Parmar D, Nelson M. Gilleece Y, et al. J Infect. 2003 Apr;46(3):204-5. doi: 10.1053/jinf.2002.1114. J Infect. 2003. PMID: 12643876 Clinical Trial. No abstract available.

6

The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients.

Gilleece Y, Torti C, Mandalia S, Gazzard BG, Pillay D, Pozniak AL. Gilleece Y, et al. HIV Med. 2003 Oct;4(4):305-10. doi: 10.1046/j.1468-1293.2003.00163.x. HIV Med. 2003. PMID: 14525540 Free article.

7

Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?

Browne R, Asboe D, Gilleece Y, Atkins M, Mandalia S, Gazzard B, Nelson M. Browne R, et al. Sex Transm Infect. 2004 Aug;80(4):326-7. doi: 10.1136/sti.2003.008532. Sex Transm Infect. 2004. PMID: 15295139 Free PMC article. No abstract available.

8

Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin.

Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, Gazzard BG, Nelson MR. Gilleece YC, et al. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):41-6. doi: 10.1097/01.qai.0000174930.64145.a9. J Acquir Immune Defic Syndr. 2005. PMID: 16123680 Clinical Trial.

9

Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir.

Tan LK, Gilleece Y, Mandalia S, Murungi A, Grover D, Fisher M, Atkins M, Nelson M. Tan LK, et al. J Viral Hepat. 2009 Jul;16(7):471-8. doi: 10.1111/j.1365-2893.2009.01084.x. Epub 2009 May 8. J Viral Hepat. 2009. PMID: 19457140

10

When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?

Read PJ, Mandalia S, Khan P, Harrisson U, Naftalin C, Gilleece Y, Anderson J, Hawkins DA, Taylor GP, de Ruiter A; London HIV Perinatal Research Group. Read PJ, et al. AIDS. 2012 Jun 1;26(9):1095-103. doi: 10.1097/QAD.0b013e3283536a6c. AIDS. 2012. PMID: 22441248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters